Internship at UC Berkeley QB3

Posted: 11/12/2025

About the Company/Organization:

UC Berkeley QB3
Type: Nonprofit/NGO
Size: https://qb3.berkeley.edu/

QB3 is the University of California’s hub for innovation and entrepreneurship in life science. The institute supports UC researchers and empowers California founders to launch startup companies and partner with industry. QB3 has a 20-year track record of spinning off innovative endeavors such as the venture capital firms Mission Bay Capital and Medtech Venture Partners; several incubators, including QB3@953 (now part of MBC Biolabs); and a health technology initiative, the UCSF Rosenman Institute. QB3 founded and operates Bakar Labs, the incubator at UC Berkeley’s Bakar BioEnginuity Hub. Companies affiliated with QB3 brought in $942 million in funding in 2022.


Internship Project/Opportunity

Location: Berkeley, CA
Anticipated internship dates: May/June 2026
Target intern experience level: Undergraduate Students
https://qb3.berkeley.edu/education/intern/

The California Institute for Quantitative Biosciences at UC Berkeley (QB3-Berkeley) partners with local biotech companies to offer hands-on summer internships to UC Berkeley undergraduates. QB3-Berkeley seeks top applicants for 10-week paid internship positions, where students will learn scientific techniques and contribute to state-of-the-art interdisciplinary research projects. Interns become paid, full-time employees of the biotech company for the duration of the internship.

Interns have been placed at these companies in the past:

  • Abalone Bio, Inc.
  • Aralez Bio
  • Amyris
  • Chan Zuckerberg Biohub
  • Cinder Biological, Inc.
  • Correlia Biosystems
  • Dahlia Biosciences, Inc.
  • Encellin
  • Eysz, Inc.
  • Huue, Inc.
  • Intact Therapeutics
  • iSono Health
  • Kryptos Biotechnologies, Inc.
  • Mantra Bio
  • Moichor Inc.
  • Nodexus
  • Pow Bio
  • Tinctorium
  • Valitor Inc.

Interns will:

  • Acquire valuable, real-world research experience and training on a long-term project;
  • Work full-time and earn a competitive salary;
  • Explore career options and define the direction for graduate studies.
  • Network with a variety of industries, QB3-Berkeley, and student researchers;
  • Work one-on-one with mentors and utilize advanced laboratory facilities;
  • Develop new technical, communication, time management, and leadership skills.

 

Eligibility

QB3-Berkeley Undergraduate Biotech Internship Program applicants must meet the following eligibility requirements:

  • Registered as a current undergraduate student with sophomore (2nd year) or junior (3rd year) standing at UC Berkeley;
  • Overall GPA of at least 3.2;
  • Undergraduate coursework in biology, chemistry, and classroom lab experience;
  • Unrestricted authorization to work in the United States;
  • Committed to full-time summer employment and will return to UC Berkeley for the Fall semester.
  • Transfer students: Completion of at least one semester of coursework at UC Berkeley;
  • International students: F-1 or J-1 visa and completion of at least one academic year (two semesters or one semester and one summer session) at UC Berkeley.

 

Contact: Email

Mark Bathe

Mark Bathe is a Professor in the Department of Biological Engineering at MIT, a Member of the Harvard Medical School Initiative for RNA Medicine, and an Associate Member of the Broad Institute of MIT & Harvard. He obtained his Doctoral Degree at MIT working in the Departments of Biological, Chemical, and Mechanical Engineering before moving to the University of Munich for his postdoctoral research in Biological Physics. He returned to MIT in 2009 to join the faculty in the Department of Biological Engineering, where he runs an interdisciplinary research group focused on engineering nucleic acids for the targeted delivery of therapeutics and vaccines, phenotypic profiling of neuronal circuits, and molecular computing and data storage. He is academic co-founder of Cache DNA and Kano Therapeutics, and in his free time he enjoys running, biking, swimming, and skiing, amongst other outdoor activities.

Xu Zhang

Dr. Zhang’s work integrates genetic engineering, electrochemistry, and device design to develop living microbial systems for bioelectronics and functional biomaterials.

Christian Euler

I am a metabolic engineer and systems biologist with research interests primarily focused on finding/developing novel biological pathways for waste upcycling. My group does “full stack” metabolic engineering, from in silico modelling and design through to bench-scale fermentation to evaluate scalability. I am also the co-founder of Phycus Biotechnologies, which makes bio-based glycolic acid using a novel, sustainable fermentation process.

NextGen Omics, Spatial & Data UK 2025

The NextGen Omics, Spatial & Data UK event, now in its 18th year, unites the multi-omics, spatial biology, and data science communities. Held annually in London, it serves as a key meeting point for influential researchers, healthcare leaders, and technology innovators from the UK and Europe. The event aims to address the complexity of interpreting and integrating multi-omics data by fostering dialogue, sharing best practices, and inspiring cross-sector collaboration among teams from academia, pharma, and biotech, ultimately aiming to accelerate the development of life-saving treatments for patients.

Alberto Donayre

Dr. Alberto J. Donayre-Torres is a Professor in the Department of Bioengineering at Universidad de Ingeniería y Tecnología (UTEC) in Lima, Peru. He holds a Ph.D. in Plant Genetics and Biotechnology from CINVESTAV-IPN, Mexico (2009), and completed postdoctoral training at the National Autonomous University of Mexico (UNAM) and Colorado State University (USA), where he spent five years advancing synthetic biology platforms for programmable biological systems. His research sits at the convergence of synthetic biology, advancing biomaterials using bioconjugation engineering (ACS Omega, 2025). He leads projects developing open-source tools for DNA assembly (pyBrick-DNA, J. Comp. Biol., 2023) and develops international collaboration on predictive biomaterial modeling AI-assisted. Dr. Donayre has supervised undergraduate and graduate research in recombinant protein synthesis, hydrogel functionalization, and bioconjugation — and actively contributes to the global synthetic biology community as co-organizer of international congresses and developer of open bioengineering platforms.

Joy Y. Zhang

Joy Y. Zhang is a Professor of Sociology and Founding Director of the Centre for Global Science and Epistemic Justice (GSEJ) at the University of Kent. Her research examines evolving science–society dynamics and their implications for the global ethical governance of emerging life sciences. Conceptually, her work advances the theorisation of cosmopolitanisation, decolonisation, commoning, epistemic justice, and subaltern politics. Empirically, her research focuses on four major scientific powers—China, India, the UK, and the US. She has studied the governance and science diplomacy of emerging life sciences—including stem cells, synthetic biology, genome editing, and experimental therapies—alongside climate politics, food movements, and environmental engineering. She currently leads three cutting-edge social research programmes on engineering biology and its applications in critical minerals, biomedicine, and agriculture, with the aim of informing social and policy deliberation in the UK and internationally. She is the author of three academic books and publishes widely in high-impact journals across the natural and social sciences. She is frequently interviewed by global media and advises leading research and policy institutions in Europe and Asia.

Delaney Beckner

Arjun Khakhar

My group focuses on using synthetic control systems to re-engineer plants, filamentous fungi, and viruses. I am passionate about fighting global hunger and malnutrition. My major hobbies are cooking, making art, and reading. Science fiction is my favorite genre and I love that my job gives me the opportunity to bring some of the things I have read about closer to reality.

Biomarkers and Precision Medicine US 2025

Biomarkers & Precision Medicine US takes place on October 27 – 28 in San Francisco, CA. Running across two full days, with 15 tracks across three dedicated programmes it’s the must attend event for those involved in bringing next-generation personalized treatments to market.

In 2025, the event will feature three core programs:

  • Biomarkers – Focusing on the discovery, validation, and application of biomarkers and diagnostics in personalized healthcare.
  • Spatial Biology for Precision Medicine – Highlighting the importance of spatial insights in the development of precision therapies.
  • Digital Pathology & AI – Exploring the integration of digital pathology and artificial intelligence in transforming clinical diagnostics.

The Biomarkers, Spatial Biology for Precision Medicine, and Digital Pathology programmes come together to create a must attend event. The programme offers opportunities to showcase the latest innovations, meet and collaborate with over 1000 senior biomarker and precision medicine scientists from the pharma and biotech industry.

Register now and book your complemetary place at the event- it includes access to over 100 presentations, opportunities to network with 80+ exhibitors, refreshments and drinks reception.

Open PhD Positions

We have two open and funded positions for new PhD students beginning as early as January 2026. One project relates to engineering synthetic microbial communities and the other is focussed on engineering microbes for critical mineral recovery.

Students may apply to ASU graduate programs in Chemical Engineering, Biological Design, Microbiology, or MCB.

This is a great opportunity, especially if you missed the Fall ’25 cycle or do not want to wait until Fall ’26.

Please reach out to Prof. Nielsen if interested or if you have any questions.

Yousong Ding

Dr. Yousong Ding received his B.S. in Applied Chemistry from Peking University in 2000, his M.S. in Chemistry (Advisor: Prof. Liangcheng Du) from the University of Nebraska–Lincoln in 2004, and his Ph.D. in Medicinal Chemistry from the University of Michigan–Ann Arbor in 2010, where he trained under Professor David Sherman. He subsequently completed postdoctoral research with Professor Frances Arnold at Caltech. In 2012, Dr. Ding returned to Michigan to join Pfizer Inc. (Kalamazoo, MI) before beginning his independent academic career at the University of Florida in July 2013. He is currently a Professor of Medicinal Chemistry at UF. Dr. Ding’s research group integrates synthetic biology, medicinal chemistry, microbiology, molecular biology, and microbiome engineering to discover and develop bioactive natural products that address current and emerging medical challenges. At UF, he has published over 60 peer-reviewed papers and filed more than 20 invention disclosures. He is also a frequent reviewer for funding agencies including the NIH, NSF, and others.

Catherine McCarthy

Catherine McCarthy serves as the Director of the National Informal STEM Education Network (NISE Network) and is Project Manager Senior for the Arizona State University Center for Innovation in Informal STEM Learning (CIISL) in the School for the Future of Innovation in Society. McCarthy has more than twenty years of experience developing, implementing, and studying STEM learning and public engagement on a variety of science and technology topics. The National Informal STEM Education Network (NISE Network) is a community of informal educators and scientists dedicated to supporting learning about science, technology, engineering, and math (STEM) across the United States.

Cresten Mansfeldt

Cresten B. Mansfeldt is an Assistant Professor of Environmental Engineering at the University of Colorado Boulder, where he leads research at the intersection of synthetic biology, environmental microbiology, and wastewater surveillance and management. His work focuses on tracking and mitigating emerging contaminants, including synthetic biology products, within urban water systems. Prof. Mansfeldt has published extensively on microbial ecology, biotechnological risk, and post-fire water impacts, and actively bridges academic, regulatory, and community sectors to advance environmental resilience.

NextGen Biomed 2025

Join the global hub for biologics innovation at NextGen Biomed 2025, where the brightest minds in drug discovery and development come together to accelerate life-saving treatments. This transformative event unites six thriving communities on one platform, empowering over 1,000 R&D experts to collaborate, innovate, and deliver breakthroughs sustainably and at scale.

Programme Highlights:
• Proteins, Antibodies & ADCs
• Peptides, Oligonucleotides & Sustainability
• Immunotherapy & Immuno-oncology
• Vaccines

From dynamic panels and expert-led workshops to unparalleled networking opportunities, NextGen Biomed 2025 offers everything you need to stay ahead in biologics R&D. Register here.

Vaughn Cooper

Vaughn Cooper, Ph.D. is an evolutionary biologist and microbiologist. He is currently Professor of Microbiology and Molecular Genetics, and Computational and Systems Biology, at the University of Pittsburgh, School of Medicine. He co-founded and until recently was Director of the Center for Evolutionary Biology and Medicine (CEBaM), which works to catalyze research and education at the interface of these disciplines. He’s also a Fellow of the American Academy of Microbiology, an elected Board member of the American Society of Microbiology (ASM), and is President-Elect of ASM in 2025-6. The Cooper laboratory studies how potential pathogens evolve to adapt to new hosts and environments, including by forming biofilm or gaining antimicrobial resistance. Recently, Dr. Cooper joined a team of scientists considering the potential risks of mirror life and is a board member of the Mirror Biology Dialogue Fund. We are proud to have founded EvolvingSTEM (http://evolvingstem.org), a comprehensive educational program that provides authentic classroom research experiences for thousands of middle and high school students in which they conduct a microbiology experiment that demonstrates evolution in action. The major goal of EvolvingSTEM is to help students see themselves as scientists and join the STEM workforce.

Dr. Cooper is also a co-founder and scientific advisor of SeqCoast Genomics, LLC and Middle Author Bioinformatics, LLC.

CRISPR Screening and Analysis

Wellcome Connecting Science presents this new two-part course offering applicants the opportunity to get hands-on with the latest CRISPR-cas technologies, at our CRISPR Screening and Analysis training course. Participants will gain skills and experience with large-scale pooled and arrayed screening, delivered by a training team of established and emerging scientists.

The virtual training will take place through July 28 to August 1, 2025, and will provide participants with an introduction to the CRISPR- Cas Toolkit, and tutorials and talks focused on resources, tools, and techniques for CRISPR screening. It will be followed up by our in-person course (September 21-26) which will focus more on the what, how, and why of CRISPR screening with intensive laboratory and computational sessions. The course will explore the application of CRISPR screens in the therapeutic areas of oncology, neurodegeneration, and immunology.

Applications close June 3, 2025.

Aditya Sarnaik

I am currently an Associate Research Professional in the School for Sustainable Engineering and the Built Environment (SSEBE) at Arizona State University, based on the Polytechnic campus. I work at the Arizona Center for Algae Technology and Innovation (AzCATI), where I contribute to applied research in algal biotechnology and sustainable biomanufacturing.

With a background in Biotechnology and formal training in biochemical engineering, I specialize in bacterial metabolic and protein engineering, focusing on both photosynthetic and non-photosynthetic bacterial systems. Currently, I am collaborating with HelioBioSys Inc. (CA, USA) on the development of bioprocesses for the production of bio-based sunscreen components derived from cyanobacteria. This work spans the entire value chain—from scale-up cultivation to downstream process optimization—at a pilot scale of over 1,000 liters. We are now progressing toward industrial-scale trials at volumes of 12,000–15,000 liters, with the goal of enabling continuous production and biomass harvesting.

Beyond research and teaching, I enjoy creative and outdoor pursuits including music (particularly singing), hiking, and wildlife photography.

Neda Bagheri

Neda Bagheri earned her doctorate in Electrical Engineering from the University of California in Santa Barbara. Her focus on control theory and dynamics piqued her interest in biology. After completing a postdoc in Biological Engineering at MIT, she joined the Chemical & Biological Engineering faculty at Northwestern University where she founded the Modeling Dynamic Life Systems (MoDyLS) Lab. In 2019, she was recruited to both the University of Washington (where she holds a joint position in Biology and Chemical Engineering) and the Allen Institute for Cell Science. In recognition for her research accomplishments and vision, Bagheri was awarded a National Science Foundation CAREER Award (2017), a Distinguished Investigator by the Washington Research Foundation (2019), and a Senior Moulton Medal (2020). She has also been honored as a keynote speaker for both national and international conferences. She serves on multiple scientific advisory and editorial boards, guiding the frontier of multidisciplinary research.

Erica Hartmann

Dr. Erica Marie Hartmann is an environmental microbiologist interested in the interaction between anthropogenic chemicals and microorganisms, as well as bio-inspired mechanisms for
controlling microbial communities. Her career began at the Johns Hopkins Bloomberg School of Public Health. She then moved to Arizona State University where she was the first graduate of the interdisciplinary Biological Design PhD program. She had two postdoctoral positions, the first, supported by a Fulbright, at the Commission for Atomic Energy in France. She began leading studies on antimicrobial chemicals and microbes found in indoor dust during her second postdoc at the Biology and the Built Environment Center at the University of Oregon. She is currently an associate professor at Northwestern University in the department of Civil and Environmental Engineering, with affiliations in Pulmonary Medicine and the Center for Synthetic Biology. She was awarded an NSF CAREER to support her work on antimicrobial textiles and is leading an investigation of the respiratory tract microbiome in the NIH-funded Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center. She is further designing new antimicrobial strategies based on bacteriophages.